Record overview
Status and phase
Status: COMPLETED
Phase: PHASE1, PHASE2
Sponsor: AstraZeneca
Condition: Advanced or Metastatic Breast Cancer, ER+ve Advanced or Metastatic Breast Cancer
NCT01625286
Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.